Guidelines International Network | Guidelines International Network (GIN)

Pharmacologic Management of Newly-Detected Atrial Fibrillation

MeSH Terms: Cardiovascular Diseases (C14); Cardiovascular System (A07); Therapeutics (E02)
Guideline Contact: Melanie Bird (mbird@aafp.org)
Date for Review: 2001-01-22
Publication Scope: assessment; management; treatment
Countries of Application: Canada; United States
Guideline Publication Status: Published
Languages: English
Authors: AAFP (US)
Publication Year: 2017

MeSH Terms: Hypertension (C14.907.489); Vascular Diseases (C14.907); Pulmonary Veno-Occlusive Disease (C14.907.690); Arterial Occlusive Diseases (C14.907.137)
Publication Scope: treatment
Guideline Publication Status: Published
Languages: English
Authors: CHEST (US)

MeSH Terms: Migraine Disorders (C10.228.140.546.399.750); Aspirin (D02.455.426.559.389.657.410.595.176); Anti-Inflammatory Agents; Non-Steroidal (D27.505.954.158.030); Transcranial Magnetic Stimulation (E02.621.820); Headache Disorders; Secondary (C10.228.140.546.699); Acetaminophen (D02.065.199.092.040)
Guideline Contact: Roberta James (roberta.james@nhs.net)
Publication Scope: management; prevention; treatment
Countries of Application: United Kingdom
Guideline Publication Status: Published
Languages: English
Authors: SIGN (GB)
Publication Year: 2018

MeSH Terms: Osteoporosis; Postmenopausal (C05.116.198.579.610); Osteoporosis (C05.116.198.579)
Guideline Contact: Andrea Hickman (ahickman@endocrine.org)
Publication Scope: implementation; management; treatment
Guideline Publication Status: Published
Languages: English
Authors: Endocrine Society
Publication Year: 2020

Guideline Contact: Ina Kopp (imwi@awmf.org)
English Title Translation: Pharmacotherapy of idiopathic pulmonary fibrosis (an update) and other progressive pulmonary fibroses
Keywords: Idiopathische Lungenfibrose, progrediente pulmonale Fibrose, progredient fibrosierende interstitielle Lungenerkrankung, Therapie, Nintedanib, Pirfenidon, Idiopathic pulmonary fibrosis,, progressive pulmonary fibrosis, progressive fibrosing interstitial lung disease, therapy, Nintedanib, Pirfenidone
Date for Review: 04/07/2027
Publication Date: 14/11/2022
Publication Scope: management
Countries of Application: Germany
Guideline Publication Status: Published
Languages: German
Authors: AWMF (DE)
Publication Year: 2022

MeSH Terms: Behaviour and Behaviour Mechanisms (F01); Exercise Movement Techniques (E02.403)
Publication Scope: counselling
Countries of Application: United Kingdom
Guideline Publication Status: Published
Languages: English
Authors: NICE (UK)
Publication Year: 2013